Analysis

Diasorin S.p.a. (DIAM) Stock Analysis

Diasorin S.p.a. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to DIAM.

websiteDIAM/analysis/DIAM

Diasorin S.p.a.

Diasorin S.p.a. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to DIAM.

Stock profile

Ticker

DIAM

Asset type

Stock

Market cap

$4.28B

Sector

Health Technology

Industry

Medical Specialties

Currency

EUR

Ticker listings

Diasorin S.p.a. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • DIA primary listing
  • 34D
  • DIAS
  • A0MTB2
  • 0GZX
  • DSRLF
  • DIAM primary listing
  • DIA1N

Latest Diasorin S.p.a. news

DiaSorin S p A : Receives 510(K) Clearance for Fully Customizable LIAISON PLEX Gastrointestinal Flex Assay

DiaSorin S p A : Receives 510(K) Clearance for Fully Customizable LIAISON PLEX Gastrointestinal Flex

DiaSorin S p A : Strengthens its Leadership of Immuno Division with the Appointment of Gabriele Allegri as President

DiaSorin S p A : Strengthens its Leadership of Immuno Division with the Appointment of Gabriele Allegri as

DiaSorin S p A : Revenues and EBITDA growth in line with FY 2025 Guidance. Proposed ordinary dividend per share of €1.30, +8.3% vs 2024

DiaSorin S p A : Revenues and EBITDA growth in line with FY 2025 Guidance. Proposed ordinary dividend per share of €1.30, +8.3% vs

DiaSorin S p A : signs strategic distribution agreement with McKesson Medical Surgical to expand access for the LIAISON NES molecular poi...

DiaSorin S p A : signs strategic distribution agreement with McKesson Medical Surgical to expand access for the LIAISON NES molecular point‑of‑care

DiaSorin S p A : introduces next-generation LIAISON QuantiFERON-TB Gold Plus II assay for the U.S. in partnership with QIAGEN

DiaSorin S p A : introduces next-generation LIAISON QuantiFERON-TB Gold Plus II assay for the U.S. in partnership with

Research sections

Valuation

Review valuation context for Diasorin S.p.a..

Future growth

Review future growth context for Diasorin S.p.a..

Past performance

Review past performance context for Diasorin S.p.a..

Financial health

Review financial health context for Diasorin S.p.a..

Dividend

Review dividend context for Diasorin S.p.a..

Management

Review management context for Diasorin S.p.a..

Ownership

Review ownership context for Diasorin S.p.a..

Other information

Review other information context for Diasorin S.p.a..

Community

Review community context for Diasorin S.p.a..